About My Health Careers Internship MedBlogs Contact us

Heart Failure and Cardiac Cell Death can be Brought to a Stop

by Rishika Gupta on March 31, 2018 at 11:25 AM
Font : A-A+

Heart Failure and Cardiac Cell Death can be Brought to a Stop

Inhibition of OMA1 which activates heart stress could be targeted for the prevention of heart failure finds a new study. The findings of this study are published in the Science Translational Medicine.

The new target, a mitochondrial protease called OMA1, is activated when the heart is under stress. Inhibition of OMA1 protects cardiomyocytes (the muscle cells of the heart), preventing their death and stemming the deterioration in heart function.


Cardiovascular disease constitute the main cause of death in industrialized societies. One of the most serious cardiovascular diseases is heart failure, which is the third leading cause of death in Spain. Heart Failure is the inability of the heart to adequately meet the energy demands of the body. Current treatment guidelines recommend changes in lifestyle, dietary restrictions, and various medical treatments.

Unfortunately, the success of these approaches is limited and varies from patient to patient. Because of this, a major economic and scientific effort is directed at identifying the cause of heart failure and ways to prevent it. Correct heart function requires a sufficient contractile capacity and a constant and controlled production of energy to supply all tissues with the oxygen they need.

Mitochondria are subcellular organelles that coordinate both energy production and the availability of calcium for contraction. Mitochondria are also the main producer in the cell of reactive oxygen species (ROS), which are toxic when produced in large quantities.

To ensure the correct function of the muscle cells in the heart, mitochondria need to maintain a defined internal structure and be able to prevent excessive ROS production during intensive contraction brought on by a high workload, hypertension, or other stress situations.

In the study, the research team led by Dr. Enríquez evaluated three independent models of heart failure that present distinct symptoms: chronic tachycardia, chronic hypertension, and myocardial ischemia with cardiac hypertrophy. Regardless of the source, stress-induced heart injury in all three models. First author Dr. Rebeca Acín Pérez explained: "Independently of the initial cause of heart failure, the three models undergo key changes related to mitochondria." These changes consist of an increase in mitochondrial ROS production followed by changes in the morphology of the inner mitochondrial membrane and a loss of energy-generating capacity, leading to cardiomyocyte death.

The research team found that the changes in mitochondrial inner membrane morphology require the activation of the protease OMA1. Acín Pérez explained that "there is just one OMA1 substrate described to date, OPA1, a mitochondrial protein responsible for maintaining the characteristic folds, or cristae, in the inner membrane."

In the study, the elimination of OMA1 prevented heart failure in all three models studied, demonstrating a direct role in the protection of cardiomyocytes. The new results identify OMA1 as a promising target for the treatment of heart failure.

Source: Eurekalert

News A-Z
News Category
What's New on Medindia
Contraceptive Pills in Polycystic Ovary Syndrome (PCOS) Curtail Type 2 Diabetes Risk
Mushroom May Help Cut Down the Odds of Developing Depression
How to Battle Boredom during COVID
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Parkinsons Disease Surgical Treatment Palpitations And Arrhythmias Congenital Heart Disease Death Facts Heart Healthy Heart Bereavement Amyotrophic Lateral Sclerosis (ALS) Pulmonary Arterial Hypertension Statins 

Recommended Reading
Double Danger for Women with Rheumatic Heart Disease
Women of childbearing age suffer from rheumatic heart disease (RHD). They might be facing a double ....
New Insights into Heart Failure Treatment
Targeting specific comorbidities and their associated symptoms could be an effective approach in ......
Varenicline Reduces Smoking Habit in Heart Attack Patients
Varenicline was found to be effective in stopping smoking in heart attack patients within the first ...
Amyotrophic Lateral Sclerosis (ALS)
Find out more about the degenerative disease- Amyotrophic lateral sclerosis....
Bereavement refers to grief, pain and sadness following the loss of a loved one, especially during t...
Congenital Heart Disease
Heart diseases that are present at birth are called “ Congenital heart diseases”....
Palpitations And Arrhythmias
Palpitations are unpleasant sensation of one’s own heartbeat....
Pulmonary Arterial Hypertension
It can be a serious condition affecting the heart. It is defined as mean pulmonary arterial pressure...
Statins are new wonder drugs that are proving to be efficacious, not merely in relieving symptoms bu...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use